Home » Topics » BioWorld Science

BioWorld Science
RSS

Eli Lilly and Company synthesizes GTPase KRAS mutant inhibitors

July 7, 2021

Kymera Therapeutics patents new PROTACs

July 7, 2021

Shionogi discloses new HDAC2 inhibitors

July 7, 2021

Vanderbilt University patents muscarinic M4 receptor antagonists

July 7, 2021

FDA clears IND for AGEN-1777

July 7, 2021

Positive phase I data for UBX-1325 in patients with advanced vascular eye disease

July 7, 2021

First patient dosed in phase IIb study of Lomecel-B in hypoplastic left heart syndrome

July 7, 2021

Positive interim data from phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

July 7, 2021

New beta-amyloid PET imaging agent [18F]Flotaza shows promise in Alzheimer's disease brain

July 7, 2021

TruLarv standardized Galleria mellonella developed for screening new antimicrobials

July 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...